CHD vs NKTR · P/E 32, rev $6.11B vs rev $21.0M
Church & Dwight Company Inc (CHD) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
CHD currently screens at market cap $23.08B and trailing P/E 32.0. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the CHD and NKTR stock pages for the full models.
Not investment advice.